Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives

Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity Angiotensin converting enzyme inhibitors: N-Substituted monocyclic and bicyclic amino acid derivatives Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at postions 2 and 5 of the hexanoic acid portion Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acid derivatives Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives Angiotensin-converting enzyme inhibitors. Perhydro-1,4-thiazepin-5-one derivatives